Lee, Myung Ah
The Catholic University of Korea Seoul St. Mary's Hospital · Catholic University of Korea
4 papers on CoChatORCID 0000-0002-1204-0574
Most cited papers
- Verified
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
O’Reilly, E. M., Oh, D.-Y., Dhani, N., Renouf, D. J., Lee, M. A., Sun, W., Fisher, G., Hezel, A., Chang, S.-C., Vlahovic, G., et al. (2019) · JAMA Oncology
Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers
Cited by 767
- Verified
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Ruan, D.-Y., Wu, H.-X., Xu, Y., Munster, P. N., Deng, Y., Richardson, G., Yan, D., Lee, M.-A., Lee, K.-W., Pan, H., et al. (2025) · Signal Transduction and Targeted Therapy
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 22
- Verified
Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study
Lee, Y. J., Suh, S.-Y., Song, J., Lee, S. S., Seo, A.-R., Ahn, H.-Y., Lee, M. A., Kim, C.-M., & Klepstad, P. (2015) · BMC Palliative Care
Pain Management and Opioid UsePharmacogenetics and Drug Metabolism
Cited by 14
- Verified
Safety and efficacy of D-1553 in KRAS G12C-mutated colorectal cancer: Results from a phase I/II study.
Ruan, D.-Y., Lee, M. A., Deng, Y., Lee, K.-W., Millward, M., Grewal, J. S., Gadgeel, S. M., Sanborn, R. E., Hou, X., Wei, S., et al. (2023) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free